Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
New research could provide useful information for cancer registries and potentially help policymakers better evaluate screening outcomes to develop more effective guidelines.
Former SCCT president Ed Nicol, MD, knows there has been interest in the potential of automated CT exams. However, he isn't so sure they are possible at this point in time for a number of reasons.
Concerningly, the number of patients diagnosed with stage 4 disease increased from 1.9% in 2019 to 6.2% in 2020, experts reported in JAMA Network Open.
Reactive axillary lymph nodes seen on screening mammograms after vaccination can last for many months and should not be cause for imaging delays, experts reported in Radiology.
After surgical excision, 10.2% of the architectural distortion cases with nonmalignant pathology at biopsy were upgraded to malignant, researchers reported in the American Journal of Roentgenology.
After witnessing a 6-fold increase in early-stage cancer diagnoses and no change in late-stage disease numbers, experts began to question ongoing screening methods.